PRRT2 and neoplasm: Of note, the engagement of CD103 in tumor-specific cytotoxic T cells with its own ligand E-cadherin has been reported to increase the interaction with the target cell, likely lowering the threshold for the TCR/CD3 signal activation while supporting polarization and granule delocalization throughout the stimulation of PLC/PKC.